Lee Bourke’s Post

📢 Excited to share our latest EMJ Neurology journal! 🧠 Here, you'll discover the latest updates in the field of neurology. You'll also find a detailed review of the 10th European Academy of Neurology (EAN) Annual Congress, and exclusive interviews with experts in neurology! 🧠 *this content is intended solely for healthcare professionals. #EMJreviews #neurology #congress #MedicalEducation

In the latest podcast for The Lancet Neurology, I interviewed Suvankar Pal from the University of Edinburgh about the MND-SMART trial. This innovative platform trial is testing multiple drugs that are already approved for other indications to see if they might also work in people with motor neuron disease. The design means results are available much faster than if a single trial was done, which is so important for people with this devastating disease. #mnd #neurology #podcast https://lnkd.in/ept8pFP7

The countdown is on! In anticipation of our upcoming launch in the USA, we are thrilled to announce the debut of our American Neurology journal, publishing in less than 2 days.   You'll have access to the latest insights in the neurology space, spanning peer-reviewed articles on trending topics, the newest research to hit the field, highlights from the American Academy of Neurology (AAN) Annual Meeting 2024, and much more.   EMJ #neurology #aan2024 #americanmedicaljournal

Manado Neurology Update (MADONA) III – Developing Knowledge to Pursue Advance Improvement in Neurology (DOPAMINE) 2024 dan BRAIN (Basic Interventional Pain Management) Workshop. Manado, November 1st, 2024. #neurology #interventionalpain #manado #needlevisualization

I am thrilled to share that my poster presentation on medication overuse headache at the 10th Congress of the European Academy of Neurology (EAN) was selected as a Breaking Insight! 🎉 Presenting my research at such a prestigious event was an incredible experience. The opportunity to discuss my findings with leading experts in the field and receive invaluable feedback was truly inspiring. Looking forward to implementing the insights gained and continuing our work towards advancing neurology research! #EAN2024 #Neurology #Research #BreakingInsight #ProudMoment

Attending the American Academy of Neurology 2024 Annual Meeting? Join our presentations and discussions on Alzheimer’s disease (AD) and visit Booth 1325 to engage with members of the Eisai Neurology team. Find a list of activities in the event program: https://ow.ly/A4zf50R7A9z #AANAM #Neurology #AlzheimersDisease

📽️ Our CEO & President, Dr. Daniel Vitt, discusses with Proactive the extended data from our phase 2 EMPhASIS trial of vidofludimus calcium in relapsing-remitting multiple sclerosis, now published in Neurology® Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology. Tune in! 🧠 ▶️ https://bit.ly/4dmr8De American Academy of Neurology #Immunic #IMUX #Vidofludimus #IMU838 #EMPhASIS #neurofilament #NfL #RRMS #MultipleSclerosis #MS #MSResearch #ClinicalTrials #Neurology #SciencePublication

🧠 World Meningitis Day - October 5, 2024 🧠 🌐 Learn More About The Global Neurology Summit 2024 - https://bit.ly/3xxjxS1 Did you know? Meningitis affects over 1.2 million people globally each year, making awareness and education crucial for prevention and treatment. 🌍 Join us at the Global Neurology Summit 2024 to delve into critical topics in neurology. This event offers insights from experts and the latest advancements in neurology to enhance your practice. 🎓💼 #WorldMeningitisDay #USA #Neurology #GlobalNeurologySummit #globalneurology #2024conference #meded #MedicalEducation #eMedEvents

With the recent approval, new diagnostic tests and a promising pipeline, meaningful progress is being made! Spherix Global Insights is tracking it, but there is no substitute to being in the midst of #alzheimerresearch at #AAIC . If #Alzheimers or #dementia has touched you personally, you know how I feel. We would be honored to be part of the solution you are creating. Let's find a time to meet. #AAIC2024 You can build #strategy from our #marketresearch #insights, #MakeBetterDecisions

Make sure to check out Dr. Daniel Vitt, CEO & President of Immunic Therapeutics, as he discusses with Proactive the extended data on the phase 2 EMPhASIS trial of vidofludimus calcium in RRMS, recently published in Neurology® Neuroimmunology & Neuroinflammation. Use the link below to learn more! #IMUX